Clinical Neurology Research Fellowship
At CU Pharmacy, our expertise is unique. The Clinical Neurology Research Fellowship is the only fellowship in the United States that specifically focuses on research and clinical practice in the field of neurology.
As part of our program, the fellow is an integral part of the multidisciplinary team in the Neurology Department at the University of Colorado Hospital’s Outpatient Clinics. The clinics offer, but are not limited to, experience in the following areas: epilepsy, multiple sclerosis, headache, trigeminal neuralgia, movement disorders, restless legs syndrome and psychiatry.
The fellow is also highly involved in research projects related to neurology. This includes planning, designing and implementing studies. Once the study is approved, the fellow will be responsible for efficiently running it. The fellow also will take the lead in data analysis and manuscript writing.
Additionally, our fellows become proficient in protocol design, good clinical practice, laboratory practices and Colorado Multiple Institutional Review Board (COMIRB) certification.
“Abortive Medication Dosing and Seizure Outcomes in the Epilepsy Monitoring Unit (EMU)”. Department of Neurology, Intradepartmental Grant Application.
Principal Investigator: Naveed Chaudhry, MD
Mentor: Jacquelyn L. Bainbridge, PharmD
“A Randomized, Double-Blind, Parallel-Group, Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Adjustment Disorder in Patients with Cancer and Other Medical Illnesses”.
COMIRB # 25-0813
Principal Investigator: Stacy Fischer, MD
Role: Pharmacy Regulatory, Oversight of Pharmaceutical Inventory
NYU – Reunion Neuroscience
A randomized, double blind, placebo-controlled parallel study of the tolerability and efficacy of high Cannabidiol (CBD) cannabis extract for the treatment of patients with Idiopathic Restless Legs Syndrome (RLS)
COMIRB # 23-0682, IND# 176150
Principal Investigator: Jacquelyn Bainbridge, PharmD
Sponsor: Biopharmaceutical Research Company, Inc. (BRC)
A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD)
COMIRB# 24-0776
Principal Investigator: Camille Hoffman, MD
Role: Pharmacy Regulatory, Oversight of Pharmaceutical Inventory
A Phase 1b study of Psilocybin Assisted Psychotherapy to address FEAR of recurrence in patients diagnosed with early-stage breast cancer and ovarian cancer in remission
COMIRB# 23-1455
Principal Investigator: Stacy Fischer MD
Co-Investigator: Jacquelyn Bainbridge, PharmD
Effects of Psilocybin with Psychological support on anhedonia in treatment resistant depression: A randomized controlled pilot trial
COMIRB # 22-1681
Principal Investigator: Andrew Novick, MD
Co-Investigator: Jacquelyn L. Bainbridge, PharmD
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer
NYU IRB: s22-00498
COMIRB # 22-1207
Principal Investigator: Stacy Fischer, MD
Co-Investigator: Jacquelyn L. Bainbridge, PharmD
Huntington’s Disease Care Grant
Anschutz Medical Campus and Department of Neurology
Support for the UPL program – upper limit grant from Colorado Medicaid to improve access to expert movement disorder care.
Principal Investigator: Lauren Seeberger, MD. And Emily Forbes, MD.
Co-Investigator: Jacquelyn Bainbridge, PharmD
Protocol Title: Colorado Cannabis Research Consortium (C2RC): Research Program for the Management of Chronic Spine Pain and Reduction of Prescription Opioid Use
Sponsor: Colorado Department of Public Health and Environment (CDPHE) Medical Marijuana Research Grant
Principal Investigator: Emily Lindley, PhD, Rachael Rzasa Lynn, MD
Co-Investigator: Jacquelyn L. Bainbridge, PharmD
2025 - 2027: Hannah Karam
2024 - 2026: Ethana Lam
2023 - 2025: Nicole Semmler
2022 - 2024: Owen Miller
2020 - 2022: Michelle Adkins
2019 - 2020: Grace Chin
2018 - 2020: Sarah Fischer/Rajkovic
July 2017 – 2018: Matthew J. Makelky Sr., PharmD
August 2015 – July 2017: Felecia Hart, PharmD, MSCS
September 2013 – September 2015: Pei Shieen Wong, PharmD
July 2012 – July 2013: Caleb Oh, PharmD
July 2011 – July 2012: Jeffery Clark, PharmD
July 2009 – July 2011: Michael Egeberg, PharmD
July 2007 – July 2009: Sarah Johnson, PharmD
October 1999 – October 2000: Scott Pollock, PharmD, BSPharm
Past Neurology Specialty Residents (No longer a program):
June 2000 – July 2001: Janina Janes, PharmD
September 1999 – October 2000: Sunita Dergalust, PharmD, BSPharm
September 1998 – October 1999: Scott Pollock, PharmD, BSPharm
Fellowship Director
Jacci Bainbridge PharmD, FCCP
Professor
Vice Chair for Research and Scholarship, Neurology Pharmacy
- Department of Clinical Pharmacy
- Anschutz Outpatient Pavilion Neurology Clinic
- Secondary Appointment - Department of Neurology, School of Medicine
Email Address:[email protected]
Primary Phone:303-724-2617
Mailing Address:
- CU Anschutz
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Office: V20-4126
Aurora, CO 80045
Dr. Bainbridge serves as a clinical pharmacy specialist at the Anschutz Outpatient Pavilion in the Neurology Clinic. This is part of the Neurology Residency Teaching Program at the University of Colorado Denver. Services provided in these clinics include: review of patient information identifying and resolving drug-related problems and consultations; recommending alternative medication therapies for patients; evaluating patients for medication toxicity; providing cost-effective recommendations; providing education to health care practitioners, patients and families; monitoring for drug interactions; avoidance of drug interactions; and reporting of drug interactions. Dr. Bainbridge manages patients with neurologic disease states to include: Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Migraine, Willis-Ekbom Disease formally known as Restless Legs Syndrome. Clinical research is a significant portion of Dr. Bainbridge’s interest. Epilepsy, Multiple Sclerosis, and several neuroprotection trials in Parkinson’s Disease, funded by the NIH, are current research projects she is involved with.
Areas of Expertise
- Neurology
Education, Licensure & Certifications
- September 1, 1995 - August 31, 1996 - Specialty Residency in Neurology, University of Colorado College of Pharmacy, Denver, Colorado
- July 1, 1993 - June 30, 1995 - Doctor of Pharmacy, University of Colorado School of Pharmacy, Denver, Colorado
- 1986 - 1988- Bachelor of Science in Pharmacy , Ohio Northern University School of Pharmacy, Ada, Ohio
Awards
- Professor of the Year. Skaggs School of Pharmacy and Pharmaceutical Sciences P2 Class, 2010, 2011, 2012.
- Professor of the Year. University of Colorado Denver P2 Class, 2008
- Preceptor of the Year. School of Pharmacy. University of Colorado Denver, 2005
- Fellow American College of Clinical Pharmacy, 2004
- Preceptor of the Year. School of Pharmacy. University of Colorado Denver, 2003